Cargando…
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges
SIMPLE SUMMARY: Risk stratification models, including the European LeukemiaNet 2017 and 2022 guidelines, categorize newly diagnosed acute myeloid leukemia (AML) patients into several subgroups of distinct genetic characteristics and disease outcomes. The intermediate-risk group remains the most hete...
Autores principales: | Awada, Hassan, Mustafa Ali, Moaath K., Thapa, Bicky, Awada, Hussein, Seymour, Leroy, Liu, Louisa, Gurnari, Carmelo, Kishtagari, Ashwin, Wang, Eunice, Baer, Maria R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454629/ https://www.ncbi.nlm.nih.gov/pubmed/36077703 http://dx.doi.org/10.3390/cancers14174166 |
Ejemplares similares
-
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics
por: Awada, Hassan, et al.
Publicado: (2021) -
What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach
por: Awada, Hussein, et al.
Publicado: (2023) -
Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes
por: Awada, Hussein, et al.
Publicado: (2022) -
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications
por: Awada, Hassan, et al.
Publicado: (2020) -
Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia
por: Teague, Destini, et al.
Publicado: (2022)